Defining overweight and obesity in pre-school children: IOTF reference or WHO standard?

L Monasta1, T Lobstein, T J Cole

  • 1Epidemiology and Biostatistics, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy. monasta@burlo.trieste.it

Insights

The International Obesity Task Force (IOTF) and WHO standards significantly differ in defining childhood overweight and obesity. This impacts prevalence rates, highlighting the need for standardized BMI cut-offs for preschool children.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Accurate identification of overweight and obesity in preschool children is crucial for early intervention.
  • Existing international datasets, such as the International Obesity Task Force (IOTF) reference and the World Health Organization (WHO) standard, are used for classification.
  • Discrepancies between these datasets can lead to variations in prevalence estimates.

Purpose of the Study:

  • To compare the performance of the IOTF reference and WHO standard in defining overweight and obesity in preschool children aged 24-60 months.
  • To analyze the differences in prevalence rates using both datasets in a specific population.

Main Methods:

  • Utilized two international datasets: the IOTF reference and the WHO standard.
  • Plotted IOTF cut-offs against WHO curves for children aged 24-60 months.
  • Compared prevalence of overweight and obesity using both definitions with 2001 Czech Republic data.

Main Results:

  • The IOTF overweight cut-off corresponds to 1.7-1.1 z-scores on the WHO chart, and the obesity cut-off shifts from 2.7 to 2.2 z-scores with age.
  • At 5 years, overweight prevalence in Czech girls was 3.4% (WHO) versus 15.3% (IOTF).
  • Discrepancies arise from differing cut-off choices and sample selection criteria for the IOTF and WHO references.

Conclusions:

  • Significant differences exist between IOTF and WHO standards for classifying overweight and obesity in preschool children.
  • Urgent research is needed to establish WHO-standard BMI cut-offs linked to health risks.
  • Standardized definitions are essential for accurate epidemiological studies and public health interventions in childhood obesity.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...